Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

Autor: Zhen Li, Ye-Gang Ma, Yongyu Liu, Chengliang Yang, Yi Ren, De-Gui Liu, Xiaobai Liu, Yao Li, Yixue Xue
Rok vydání: 2012
Předmět:
Lung Neoplasms
Angiogenesis
Tumor Physiology
Cancer Treatment
lcsh:Medicine
medicine.disease_cause
Lung and Intrathoracic Tumors
Metastasis
chemistry.chemical_compound
Small Cell Lung Cancer
Cell Movement
Molecular Cell Biology
Basic Cancer Research
lcsh:Science
Multidisciplinary
Neovascularization
Pathologic

Cell Cycle
Cell migration
Cell cycle
Cell biology
Oncology
Medicine
RNA Interference
Signal Transduction
Research Article
STAT3 Transcription Factor
Drugs and Devices
Curcumin
Antineoplastic Agents
Biology
Signaling Pathways
Complementary and Alternative Medicine
Cell Line
Tumor

medicine
Humans
Cyclin B1
Cell Proliferation
Janus Kinases
Cell growth
Interleukin-6
lcsh:R
Cancers and Neoplasms
Small Cell Lung Carcinoma
Matrix Metalloproteinases
chemistry
Ethnopharmacology
Cancer research
STAT protein
lcsh:Q
Janus kinase
Carcinogenesis
Zdroj: PLoS ONE
PLoS ONE, Vol 7, Iss 5, p e37960 (2012)
ISSN: 1932-6203
Popis: Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development. However, little is known about its anti-tumor mechanism in small cell lung cancer (SCLC). In this study, we found that curcumin can inhibit SCLC cell proliferation, cell cycle, migration, invasion and angiogenesis through suppression of the STAT3. SCLC cells were treated with curcumin (15 µmol/L) and the results showed that curcumin was effective in inhibiting STAT3 phosphorylation to downregulate of an array of STAT3 downstream targets ,which contributed to suppression of cell proliferation, loss of colony formation, depression of cell migration and invasion. Curcumin also suppressed the expression of proliferative proteins (Survivin, Bcl-X(L) and Cyclin B1), and invasive proteins (VEGF, MMP-2, MMP-7 and ICAM-1). Knockdown of STAT3 expression by siRNA was able to induce anti-invasive effects in vitro. In contrast, activation of STAT3 upstream of interleukin 6 (IL-6) leads to the increased cell proliferation ,cell survival, angiogenesis, invasion, migration and tumor growth. Our findings illustrate the biologic significance of IL-6/JAK/STAT3 signaling in SCLC progression and provide novel evidence that the pathway may be a new potential target for therapy of SCLC. It was concluded that curcumin is a potent agent in the inhibition of STAT3 with favorable pharmacological activity,and curcumin may have translational potential as an effective cancer therapeutic or preventive agent for SCLC.
Databáze: OpenAIRE